Thoracic Research and Practice
Review

Non-astmatic Eosinophilic Bronchitis

1.

Department of Pulmonary Diseases, Bursa Yüksek İhtisas Training and Research Hospital, Health Sciences University, Bursa, Turkey

Thorac Res Pract 2018; 19: 41-45
DOI: 10.5152/TurkThoracJ.2017.17017
Read: 4896 Downloads: 1045 Published: 18 July 2019

Abstract

Non-asthmatic eosinophilic bronchitis (NAEB) is eosinophilic inflammation of the respiratory tract, without any bronchospasm. In this article, we want to draw attention to the NAEB. It should also be considered in differential diagnosis of chronic cough. Eosinophilia is present in all induced or spontaneous sputum samples of NAEB patients. NAEB patients and asthmatic patients have similar airway inflammation. Remarkably, NAEB mainly occurs in the lower airways. Unlike asthma, mast cells in NAEB are active in the bronchial epithelium. Diagnosis is based on the clinical, radiological, and spirometric measurements of other causes of chronic cough (Post-nasal discharge syndrome, asthma, gastroesophageal reflux etc.) and the assessment of inflammation in the lower respiratory tract. Airway inflammation can be assessed by sputum induction. The main treatment is anti-inflammatory therapy with inhaled corticosteroids and taking protective measures if inflammation is due to occupational exposure or allergen inhalation. If NAEB is untreated, it may be transient, episodic, or persistent; rarely, long-term oral steroid treatment may be required in patients. There is a requirement for studies that investigate the role of non-invasive markers of chronic inflammation associated with NAEB and the effectiveness of other treatments.

 

 

Cite this article as: Yıldız T, Dülger S. Non-astmatic eosinophilic bronchitis. Turk Thorac J 2018; 19: 41-5.

Files
EISSN 2979-9139